Clinical Trial

A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The main purpose of the study is to evaluate the efficacy and safety of ecnoglutide injections versus placebo in obese participants with KOA.
Trial Details
NCT Number NCT07734311
Lead Sponsor Hangzhou Sciwind Biosciences Co., Ltd.
Conditions Knee Osteoarthritis, Obesity
Enrollment 360 participants
Start Date 2026-07-31
Primary Completion 2028-05-31 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-29